An increasing pathomorphism of pulmonary tuberculosis. Is there a therapeutic role for novel antimicrobial compounds effective on Mycobacterium tuberculosis?

被引：0
|
作者：
Roberto Manfredi
Sergio Sabbatani
Leonardo Calza
机构：
[1] University of Bologna,Infectious Diseases
[2] S. Orsola Hospital,undefined
来源：
Retrovirology | / 7卷
关键词：
Tuberculosis; Mycobacterium Tuberculosis; Bronchoalveolar Lavage; Linezolid; Pulmonary Tuberculosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An increasing pathomorphism of pulmonary tuberculosis. Is there a therapeutic role for novel antimicrobial compounds effective on Mycobacterium tuberculosis?
    Manfredi, Roberto
    Sabbatani, Sergio
    Calza, Leonardo
    RETROVIROLOGY, 2010, 7 : 68 - 68
  • [2] Increasing Pathomorphism of Pulmonary Tuberculosis. An Observational Study of Slow Clinical, Microbiological and Imaging Response of Lung Tuberculosis to Specific Treatment. Which Role for Linezolid?
    Manfredi, Roberto
    Nanetti, Anna
    Dal Monte, Paola
    Calza, Leonardo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (04): : 297 - 303
  • [3] Organic arsenic compounds in pulmonary tuberculosis.
    Guy, J
    Page, GB
    LANCET, 1924, 1 : 845 - 847
  • [4] Identification and purification of a novel superantigen from Mycobacterium tuberculosis.
    Doyle, CK
    Rich, RR
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1626 - 1626
  • [5] Antimicrobial Peptide against Mycobacterium Tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis
    Pelaez Coyotl, Erika A.
    Barrios Palacios, Jacqueline
    Mucino, Gabriel
    Moreno-Blas, Daniel
    Costas, Miguel
    Montiel Montes, Teresa
    Diener, Christian
    Uribe-Carvajal, Salvador
    Massieu, Lourdes
    Castro-Obregon, Susana
    Espinosa, Octavio Ramos
    Mata Espinosa, Dulce
    Barrios-Payan, Jorge
    Leon Contreras, Juan Carlos
    Corzo, Gerardo
    Hernandez-Pando, Rogelio
    Del Rio, Gabriel
    PHARMACEUTICS, 2020, 12 (11) : 1 - 24
  • [6] Novel inhibitors of InhA, the enoyl reductase from mycobacterium tuberculosis.
    Tonge, PJ
    Sullivan, TJ
    Novichenok, P
    Truglio, JJ
    Kisker, C
    Johnson, F
    Slayden, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U164 - U164
  • [7] α-Galactosylceramide as a Therapeutic Agent for Pulmonary Mycobacterium tuberculosis Infection
    Sada-Ovalle, Isabel
    Skoeld, Markus
    Tian, Tian
    Besra, Gurdyal S.
    Behar, Samuel M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (06) : 841 - 847
  • [8] WAYS OF INCREASING EFFECTIVE TREATMENT OF PATIENTS WITH PULMONARY TUBERCULOSIS
    BATMANOV, NY
    SOVETSKAYA MEDITSINA, 1975, (01): : 81 - 84
  • [9] Attacking the oxidative defense system of Mycobacterium tuberculosis by antimicrobial compounds
    Ruecker, N.
    Koch, O.
    Heller, K.
    Stuhlmann, F.
    Schmitt, S.
    Khandavalli, P. C.
    Schinzer, D.
    Flohe, L.
    Selzer, P. M.
    Bange, F. -C.
    Jaeger, T.
    Ruecker, N.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 301 : 53 - 53
  • [10] The Role of Lipid Raft Aggregation in the Infection of Type II Pneumocytes by Mycobacterium tuberculosis.
    Coulson, K. F.
    Reaves, B.
    Karls, R.
    Quinn, F.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
12345